Management of Pediatric Pleural Empyema: Insights from a Retrospective Cohort Study
Overview
This study characterizes pediatric parapneumonic empyema by analyzing clinical, biochemical, and radiological parameters, revealing that treatment decisions are primarily driven by clinical presentation rather than imaging. The findings highlight the significant role of video-assisted thoracic surgery (VATS) in managing complicated cases.
Background
Pediatric pleural empyema, a serious complication of pneumonia, occurs in approximately 0.6% of cases and is associated with considerable morbidity. Understanding the management strategies and outcomes is crucial for improving patient care, especially as the incidence of empyema remains significant despite advances in vaccination and treatment protocols. This study provides insights into the clinical decision-making process for treating this condition in children.
Data Highlights
Parameter
Value
Median age of patients
4 years
Median time to initial intervention
2 days
Duration of chest-tube drainage
21.2 ± 11.5 days
Median hospital stay
27 days
Drainage duration (VATS vs. chest-tube)
9.5 vs. 19 days
Key Findings
42.4% of patients underwent primary VATS after a median of 4.5 days.
Initial chest-tube drainage was performed in 19 patients, with a mean drainage duration of 21.2 days.
Dyspnea was a strong predictor for selecting VATS as the initial treatment (OR 18.0).
Imaging findings on thoracic ultrasound did not significantly influence the choice of initial intervention.
CT scans identified complications and were associated with prolonged hospitalization.
Clinical Implications
The study underscores the importance of clinical assessment in guiding treatment decisions for pediatric pleural empyema, with VATS being favored in complicated cases. Clinicians should consider the patient's clinical presentation over imaging results when determining the initial management approach.
Conclusion
This research highlights the need for standardized management algorithms that integrate clinical, laboratory, and imaging data for pediatric pleural empyema. The findings advocate for a symptom-driven approach to treatment.
